Cargando…
The utility of a genetic progression risk test for Barrett esophagus
This study sought to characterize the utility of a gene methylation-based biomarker test that has been validated to predict progression towards esophageal adenocarcinoma. Barrett esophagus (BE) is a precursor condition for esophageal adenocarcinoma (EAC) with somewhat variable approaches among gastr...
Autores principales: | Gong, Dennis, Lunz, Daniel, Stover, James S., Meltzer, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10662832/ https://www.ncbi.nlm.nih.gov/pubmed/36123898 http://dx.doi.org/10.1097/MD.0000000000030503 |
Ejemplares similares
-
Risk Factors for Progression of Barrett’s Esophagus to High Grade Dysplasia and Esophageal Adenocarcinoma
por: Kambhampati, Swetha, et al.
Publicado: (2020) -
Risk of progression of Barrett's esophagus in patients with cirrhosis
por: Apfel, Tehilla, et al.
Publicado: (2017) -
Histopathology in Barrett Esophagus and Barrett Esophagus-Related Dysplasia
por: Grin, Andrea, et al.
Publicado: (2014) -
Biomarkers for Risk Stratification of Neoplastic Progression in Barrett Esophagus
por: Kerkhof, Marjon, et al.
Publicado: (2007) -
Barrett's esophagus: The pathomorphological and molecular genetic keystones of neoplastic progression
por: Maslyonkina, Ksenia S., et al.
Publicado: (2021)